Logo Image
|Articles|February 1, 2002

Pharmaceutical Technology

  • Pharmaceutical Technology-02-02-2002
  • Volume 26
  • Issue 2

Using Earned-Value Analysis to Better Manage Projects

EVA takes into account a project's schedule and budget to determine the true cost performance.
External Link - article-9503.pdf

Articles in this issue

over 24 years ago

Microbial Bioburden on Oral Solid Dosage Forms

over 24 years ago

Overview of Technologies Supporting Security Requirements in 21 CFR Part 11, Part I

over 24 years ago

Modernizing Pharmaceutical Manufacturing

over 24 years ago

The Role of Computational Fluid Dynamics in the Pharmaceutical Industry

over 24 years ago

Available Guidance and Best Practices for Conducting Forced Degradation Studies

over 24 years ago

Outsourcing Outlook

over 24 years ago

Effect of Formulation and Process Variables on Matrix Erosion and Drug Release from a Multiunit Erosion Matrix of a Poorly Soluble Drug

Related to this article

View more
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Power of Two One-Sided Tests with Unequal Variances
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Read more
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Read more